Pharmagreen Biotech, Inc. (NASDAQ:PHBI) | WebDisclosure

Basculer en Français

9904	Companies
199533	Keywords
130386	Articles
106040	Press releases

Headlines Articles Press releases Pharmagreen Biotech, Inc.

Home
Companies
Pharmagreen Biotech, Inc.

PRESS RELEASE

published on 01/24/2024 at 13:00, 2 years ago

PHBI - Pharmagreen Signs Supply Contract and Trade Marked Name Use of SierraSil(R) in Its’ Nutraceutical Formulations
Pharmagreen Biotech, Inc., (OTC PINK:PHBI) signed a supply agreement with SierraSil® Health Inc., allowing the incorporation of SierraSil® minerals into its MaxGenomic® formulations. This agreement aims to promote joint tissue detoxification and aid DNA repair with the use of beta-glucans, polysaccharides, and minerals. Pharmagreen is also preparing to launch new gummy products and a pre-workout one-shot formula, all sugar-free and designed to promote wellness. The company's goal is to achieve positive cash flow by year-end and continue developing innovative nutraceutical products.

Pharmagreen Biotech Inc SierraSil Minerals MaxGenomic Formulations Nutraceutical Products Wellness Benefits

Accesswire

Published on 02/20/2026 at 18:30, 12 minutes ago

Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 2 hours 57 minutes ago

Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 4 hours 12 minutes ago

Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 14:08, 4 hours 34 minutes ago

Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange
Published on 02/20/2026 at 14:00, 4 hours 42 minutes ago

Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors

View all ACCESSWIRE

EQS Group

Published on 02/20/2026 at 18:36, 5 minutes ago

EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 10 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:23, 18 minutes ago

POS-Transaction in Own Shares
Published on 02/20/2026 at 18:00, 41 minutes ago

Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 41 minutes ago

Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations

Les Echos

Published on 02/20/2026 at 18:00, 42 minutes ago

TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 18:00, 42 minutes ago

TERACT - Résiliation du contrat de liquidité
Published on 02/20/2026 at 17:35, 1 hour 7 minutes ago

CHIFFRE D'AFFAIRES 2025
Published on 02/20/2026 at 09:28, 9 hours 14 minutes ago

Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026
Published on 02/20/2026 at 09:28, 9 hours 14 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026

View all LES ECHOS COMFI WIRE